ADRB2 and neoplasm: Studies in human prostate cancer (PCa) cell lines showed that NE activates β2-AR on dormant disseminated tumor cells (DTCs) within the bone marrow niche, leading to downregulation of cell cycle inhibitors: p21 and p27.